Immune responses against Marek's disease virus

Animal Health Research Reviews

Volumn 11, Issue 2, 2010, Pages 123-134

  Parvizi, Payvand ^a   Abdul Careem, Mohamed Faizal ^a   Haq, Kamran ^a   Thanthrige Don, Niroshan ^a   Schat, Karel A ^b   Sharif, Shayan ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

chickens; genetic resistance; herpesvirus; immune response; Marek's disease; vaccine

Indexed keywords

CYTOKINE;

ADAPTIVE IMMUNITY; ANIMAL; CHICKEN; GENE EXPRESSION REGULATION; IMMUNOLOGY; MARDIVIRUS; MAREK DISEASE; METABOLISM; PHYSIOLOGY; REVIEW; VIROLOGY;

ADAPTIVE IMMUNITY; ANIMALS; CHICKENS; CYTOKINES; GENE EXPRESSION REGULATION; MARDIVIRUS; MAREK DISEASE;

EID: 79953020403     PISSN: 14662523     EISSN: 14752654     Source Type: Journal    
DOI: 10.1017/S1466252310000022     Document Type: Review

References (147)

1. Abdul-Careem MF, Hunter BD, Sarson AJ, Mayameei A, Zhou H and Sharif S (2006). Marek's disease virus-induced transient paralysis is associated with cytokine gene expression in the nervous system. Viral Immunology 19: 167-176.
2. Abdul-Careem MF, Haq K, Shanmuganathan S, Read LR, Schat KA, Heidari M and Sharif S (2009). Induction of innate host responses in the lungs of chickens following infection with a very virulent strain of Marek's disease virus. Virology 2: 250-7. Epub 2009 Sep 4.
3. Abdul-Careem MF, Hunter BD, Parvizi P, Haghighi HR, Thanthrige-Don N and Sharif S (2007). Cytokine gene expression patterns associated with immunization against Marek's disease in chickens. Vaccine 25: 424-432.
4. Abdul-Careem MF, Hunter BD, Lee LF, Fairbrother JH, Haghighi HR, Read L, Parvizi P, Heidari M and Sharif S (2008a). Host responses in the bursa of Fabricius of chickens infected with virulent Marek's disease virus. Virology 379: 256-265.
5. Abdul-Careem MF, Hunter BD, Sarson AJ, Parvizi P, Haghighi HR, Read L, Heidari M and Sharif S (2008b). Host responses are induced in feathers of chickens infected with Marek's disease virus. Virology 370: 256-265.
6. Abdul-Careem MF, Read LR, Parvizi P, Thanthrige-Don N and Sharif S (2009). Marek's disease virus-induced expression of cytokine genes in feathers of genetically defined chickens. Developmental and Comparative Immunology 33: 618-623.
7. Abplanalp H, Schat KA and Calnek BW (1984). Genetic resistance to Marek's disease in congenic strains of chickens. In: Calnek BW and Spencer JL (eds) Proceedings of International Symposium on Marek's Disease. Kenneth Square, PA: American Association of Avian Pathologists, pp. 347-358.
8. Akbari MR, Haghighi HR, Chambers JR, Brisbin J, Read LR and Sharif S (2008). Expression of antimicrobial peptides in cecal tonsils of chickens treated with probiotics and infected with Salmonella. Clinical and Vaccine Immunology 15: 1689-1693.
9. Bacon LD and Witter RL (1993). Influence of B haplotype on the relative efficacy of Marek's disease vaccines of different serotypes. Avian Diseases 37: 53-59.
10. Bacon LD and Witter RL (1994a). Serotype specificity of B-haplotype influence on the relative efficacy of Marek's disease vaccines. Avian Diseases 38: 65-71.
11. Bacon LD and Witter RL (1994b). B haplotype influence on the relative efficacy of Marek's disease vaccines in commercial chickens. Poultry Science 73: 481-487.
12. Bacon LD and Witter RL (1995). Efficacy of Marek's disease vaccines in Mhc heterozygous chickens: MHC congenic inbred line F1 matings. Journal of Heredity 86: 269-273.
13. Bacon LD, Hunt HD and Cheng HH (2001). Genetic resistance to Marek's disease. Current Topics in Microbiology and Immunology 255: 121-142.
14. Baggiolini M and Clark-Lewis I (1992). Interleukin-8, a chemotactic and inflammatory cytokine. FEBS letters 307: 97-101.
15. Baigent SJ and Davison F (2004). Marek's disease virus: biology and life cycle. In: Davison F and Nair V (eds) Marek's Disease: An Evolving Problem. London: Elsevier, pp. 62-78.
16. Baigent SJ, Smith LP, Nair VK and Currie RJ (2006). Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection. Veterinary Immunology and Immunopathology 112: 78-86.
17. Barrow AD, Burgess SC, Baigent SJ, Howes K and Nair VK (2003). Infection of macrophages by a lymphotropic herpesvirus: a new tropism for Marek's disease virus. Journal of General Virology 84: 2635-2645.
18. Biely J, Palmer VE, Lerner IM and Asmundson VS (1933). Inheritance of resistance to fowl paralysis (Neurolymphomatosis Gallinarum). Science (New York, NY) 78: 42-51.
19. Biggs PM (2001). The history and biology of Marek's disease virus. In: Hirai K (ed.) Marek's Disease. Berlin, Heidelberg, NewYork: Springer-Verlag, pp. 1-24.
20. Biron CA (1998). Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections. Seminars in Immunology 10: 383-390.
21. Bogdan C (2001). Nitric oxide and the immune response. Nature Immunology 2: 907-916.
22. Boyd A, Philbin VJ and Smith AL (2007). Conserved and distinct aspects of the avian Toll-like receptor (TLR) system: implications for transmission and control of bird-borne zoonoses. Biochemical Society Transactions 35: 1504-1507.
23. Briles WE, Stone HA and Cole RK (1977). Marek's disease: effects of B histocompatibility alloalleles in resistant and susceptible chicken lines. Science 195: 193-195.
24. Bublot M and Sharma J (2004). Vaccination against Marek's disease. In: Davison F and Nair V (eds) Marek's Disease an Evolving Problem. London: Elsevier, pp. 168-185.
25. Bumstead N (1998). Genomic mapping of resistance to Marek's disease. Avian Pathology 27: 78-81.
26. Bumstead N and Kaufman J (2004). Genetic resistance to Marek's disease. In: Davison F and Nair V (eds) Marek's Disease: An Evolving Problem. London: Elsevier, pp. 112-125.
27. Burgess SC, Young JR, Baaten BJ, Hunt L, Ross LN, Parcells MS, Kumar PM, Tregaskes CA, Lee LF and Davison TF (2004). Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30). Proceedings of the National Academy of Sciences of the United States of America 101: 13879-13884.
28. Buscaglia C, O'Connell PH, Jarosinski KW, Pevzner I and Schat KA (2009). Selection for increased nitric oxide production does not increase resistance to Marek's disease in a primary broiler breeder line. Avian Diseases 53: 336-340.
29. Buza JJ and Burgess SC (2007). Modeling the proteome of a Marek's disease transformed cell line: a natural animal model for CD30 overexpressing lymphomas. Proteomics 7: 1316-1326.
30. Calnek BW (1982). Marek's disease vaccines. Developments in Biological Standardization 52: 401-405.
31. Calnek BW (1986). Marek's disease-a model for herpesvirus oncology. Critical Reviews in Microbiology 12: 293-320.
32. Calnek BW (2001). Pathogenesis of Marek's disease virus infection. In: Hirai K (ed.) Marek's Disease. Berlin, Heidelberg, New York: Springer-Verlag, pp. 25-55.
33. Calnek BW, Adldinger HK and Kahn DE (1970). Feather follicle epithelium: a source of enveloped and infectious cellfree herpesvirus from Marek's disease. Avian Diseases 14: 219-233.
34. Carriel-Gomes MC, Kratz JM, Barracco MA, Bachere E, Barardi CR and Simoes CM (2007). In vitro antiviral activity of antimicrobial peptides against herpes simplex virus 1, adenovirus, and rotavirus. Memorias do Instituto Oswaldo Cruz 102: 469-472.
35. Chen X and Velicer LF (1992). Expression of the Marek's disease virus homolog of herpes simplex virus glycoprotein B in Escherichia coli and its identification as B antigen. Journal of Virology 66: 4390-4398.
36. Chen XB, Sondermeijer PJ and Velicer LF (1992). Identification of a unique Marek's disease virus gene which encodes a 38-kilodalton phosphoprotein and is expressed in both lytically infected cells and latently infected lymphoblastoid tumor cells. Journal of Virology 66: 85-94.
37. Cheng HH, Zhang Y and Muir WM (2007). Evidence for widespread epistatic interactions influencing Marek's disease virus viremia levels in chicken. Cytogenetic and Genome Research 117: 313-318.
38. Churchill AE, Chubb RC and Baxendale W (1969a). The attenuation, with loss of oncogenicity, of the herpes-type virus of Marek's disease (strain HPRS-16) on passage in cell culture. Journal of General Virology 4: 557-564.
39. Churchill AE, Payne LN and Chubb RC (1969b). Immunization against Marek's disease using a live attenuated virus. Nature 221: 744-747.
40. Cole RK (1968). Studies on genetic resistance to Marek's disease. Avian Diseases 12: 9-28.
41. Cui X, Lee LF, Reed WM, Kung HJ and Reddy SM (2004). Marek's disease virus-encoded vIL-8 gene is involved in early cytolytic infection but dispensable for establishment of latency. Journal of Virology 78: 4753-4760.
42. Cui ZZ, Lee LF, Liu JL and Kung HJ (1991). Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells. Journal of Virology 65: 6509-6515.
43. Cumberbatch JA, Brewer D, Vidavsky I and Sharif S (2006). Chicken major histocompatibility complex class II molecules of the B haplotype present self and foreign peptides. Animal Genetics 37: 393-396.
44. Dalgaard TS, Hojsgaard S, Skjodt K and Juul-Madsen HR (2003). Differences in chicken major histocompatibility complex (MHC) class I alpha gene expression between Marek's disease-resistant and-susceptible MHC haplotypes. Scandinavian Journal of Immunology 57: 135-143.
45. Davison F and Kaiser P (2004). Immunity to Marek's disease. In: Davison F and Nair V (eds) Marek's Disease: An Evolving Problem, 1st edn. London: Elsevier, pp. 126-139.
46. Degen WG, Daal N, Rothwell L, Kaiser P and Schijns VE (2005). Th1/Th2 polarization by viral and helminth infection in birds. Veterinary Microbiology 105: 163-167.
47. Ding AH and Lam KM (1986). Enhancement by interferon of chicken splenocyte natural killer cell activity against Marek's disease tumor cells. Veterinary Immunology and Immunopathology 11: 65-72.
48. Djeraba A, Musset E, Bernardet N, Le Vern Y and Quéré P (2002). Similar pattern of iNOS expression, NO production and cytokine response in genetic and vaccination-acquired resistance to Marek's disease. Veterinary Immunology and Immunopathology 85: 63-75.
49. Fukui A, Inoue N, Matsumoto M, Nomura M, Yamada K, Matsuda Y, Toyoshima K and Seya T (2001). Molecular cloning and functional characterization of chicken toll-like receptors. A single chicken toll covers multiple molecular patterns. Journal of Biological Chemistry 276: 47143-47149.
50. Ganz T (2003). Defensins: antimicrobial peptides of innate immunity. Nature Reviews Immunology 3: 710-720.
51. Garcia-Camacho L, Schat KA, Brooks R Jr and Bounous DI (2003). Early cell-mediated immune responses to Marek's disease virus in two chicken lines with defined major histocompatibility complex antigens. Veterinary Immunology and Immunopathology 95: 145-153.
52. Gavora JS and Spencer JL (1979). Studies on genetic resistance of chickens to Marek's disease: a review. Comparative Immunology, Microbiology and Infectious Diseases 2: 359-371.
53. Giansanti F, Giardi MF and Botti D (2006). Avian cytokines: an overview. Current Pharmaceutical Design 12: 3083-3099.
54. Gimeno IM (2008). Marek's disease vaccines: a solution for today but a worry for tomorrow? Vaccine 26: C31-C41.
55. Gimeno IM, Witter RL, Hunt HD, Reddy SM and Reed WM (2004). Biocharacteristics shared by highly protective vaccines against Marek's disease. Avian Pathology 33: 59-68.
56. Haeri M, Read LR, Wilkie BN and Sharif S (2005). Identification of peptides associated with chicken major histocompatibility complex class II molecules of B21 and B19 haplotypes. Immunogenetics 56: 854-859.
57. Heidari M, Huebner M, Kireev D and Silva RF (2008). Transcriptional profiling of Marek's disease virus genes during cytolytic and latent infection. Virus Genes 36: 383-392.
58. Heifetz EM, Fulton JE, O'Sullivan NP, Arthur JA, Wang J, Dekkers JCM and Soller M (2007). Mapping quantitative trait loci affecting susceptibility to Marek's disease virus in a backcross population of layer chickens. Genetics 177: 2417-2431.
59. Heifetz EM, Fulton JE, O'Sullivan NP, Arthur JA, Cheng H, Wang J, Soller M and Dekkers JC (2009). Mapping QTL affecting resistance to Marek's disease in an F6 advanced intercross population of commercial layer chickens. BMC Genomics 10: 1-17.
60. Heller ED and Schat KA (1987). Enhancement of natural killer cell activity by Marek's disease vaccines. Avian Pathology 16: 51-60.
61. Hepkema BG, Blankert JJ, Albers GAA, Tilanus MGJ, Egberts E, Vanderzijpp AJ and Hensen EJ (1993). Mapping of susceptibility to Marek's disease within the major histocompatibility (B) complex by refined typing of white leghorn chickens. Animal Genetics 24: 283-287.
62. Islam A and Walkden-Brown SW (2007). Quantitative profiling of the shedding rate of the three Marek's disease virus (MDV) serotypes reveals that challenge with virulent MDV markedly increases shedding of vaccinal viruses. Journal of General Virology 88: 2121-2128.
63. Jarosinski KW, Jia W, Sekellick MJ, Marcus PI and Schat KA (2001). Cellular responses in chickens treated with IFNalpha orally or inoculated with recombinant Marek's disease virus expressing IFN-alpha. Interferon Cytokine Research 21: 287-296.
64. Jarosinski KW, Yunis R, O'Connell PH, Markowski-Grimsrud CJ and Schat KA (2002). Influence of genetic resistance of the chicken and virulence of Marek's disease virus (MDV) on nitric oxide responses after MDV infection. Avian Diseases 46: 636-649.
65. Jarosinski KW, Njaa BL, O'Connell PH and Schat KA (2005). Proinflammatory responses in chicken spleen and brain tissues after infection with very virulent plus Marek's disease virus. Viral Immunology 18: 148-161.
66. Jenkins KA, Lowenthal JW, Kimpton W and Bean AG (2009). The in vitro and in ovo responses of chickens to TLR9 subfamily ligands. Developmental and Comparative Immunology 33: 660-667.
67. Johnson EA, Burke CN, Fredrickson TN and DiCapua RA (1975). Morphogenesis of Marek's disease virus in feather follicle epithelium. Journal of National Cancer Institute 55: 89-99.
68. Juul-Madsen HR, Dalgaard TS and Afanassieff M (2000). Molecular characterization of major and minor MHC class I and II genes in B-21-like haplotypes in chickens. Animal Genetics 31: 252-261.
69. Kaiser P, Underwood G and Davison F (2003). Differential cytokine responses following Marek's disease virus infection of chickens differing in resistance to Marek's disease. Journal of Virology 77: 762-768.
70. Kaiser P, Rothwell L, Avery S and Balu S (2004). Evolution of the interleukins. Developmental and Comparative Immunology 28: 375-394.
71. Kaiser P, Poh TY, Rothwell L, Avery S, Balu S, Pathania US, Hughes S, Goodchild M, Morrell S, Watson M, Bumstead N, Kaufman J and Young JR (2005). A genomic analysis of chicken cytokines and chemokines. Journal of Interferon and Cytokine Research 25: 467-484.
72. Kano R, Konnai S, Onuma M and Ohashi K (2009). Cytokine profiles in chickens infected with virulent and avirulent Marek's disease viruses: interferon-gamma is a key factor in the protection of Marek's disease by vaccination. Microbiology and Immunology 53: 224-232.
73. Karaca G, Anobile J, Downs D, Burnside J and Schmidt CJ (2004). Herpesvirus of turkeys: microarray analysis of host gene responses to infection. Virology 318: 102-111.
74. Karpala AJ, Lowenthal JW and Bean AG (2008). Activation of the TLR3 pathway regulates IFNbeta production in chickens. Developmental and Comparative Immunology 32: 435-444.
75. Kaufman J and Salomonsen J (1997). The “Minimal Essential MHC” revisited: both peptide-binding and cell surface expression level of MHC molecules are polymorphisms selected by pathogens in chickens. Hereditas 127: 67-73.
76. Kaufman J, Volk H and Wallny HJ (1995). A “Minimal Essential MHC” and an “unrecognized MHC”: two extremes in selection for polymorphism. Immunological Reviews 143: 63-88.
77. Kaufman J, Milne S, Goebel TW, Walker BA, Jacob JP, Auffray C, Zoorob R and Beck S (1999). The chicken B locus is a minimal essential major histocompatibility complex. Nature 401: 923-925.
78. Kindt TJ, Goldsby RA and Osborne BA (2007). Chapter 2: Cells and organs of the immune system. In Immunology, 6th edn. W.H. Freeman and Company, NewYork, 23-52.
79. Koch M, Camp S, Collen T, Avila D, Salomonsen J, Wallny HJ, Van Hateren A, Hunt L, Jacob JP, Johnston F, Marston DA, Shaw I, Dunbar PR, Cerundolo V, Jones EY and Kaufman J (2007). Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding. Immunity 27: 885-899.
80. Kogut MH, Iqbal M, He H, Philbin V, Kaiser P and Smith A (2005). Expression and function of Toll-like receptors in chicken heterophils. Developmental and Comparative Immunology 29: 791-807.
81. Kumar S, Buza JJ and Burgess SC (2009). Genotype-dependent tumor regression in Marek's disease mediated at the level of tumor immunity. Cancer Microenvironment 2: 23-31.
82. Leite-De-Moraes MC, Hameg A, Pacilio M, Koezuka Y, Taniguchi M, Van Kaer L, Schneider E, Dy M and Herbelin A (2001). IL-18 enhances IL-4 production by ligandactivated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. Journal of Immunology 166: 945-951.
83. Li S, Zadworny D, Aggrey SE and Kuhnlein U (1998). Mitochondrial PEPCK: a highly polymorphic gene with alleles co-selected with Marek's disease resistance in chickens. Animal Genetics 29: 395-397.
84. Lillehoj HS, Lillehoj EP, Weinstock D and Schat KA (1988). Functional and biochemical characterizations of avian T lymphocyte antigens identified by monoclonal antibodies. European Journal of Immunology 18: 2059-2065.
85. Lipkin E, Fulton J, Cheng H, Yonash N and Soller M (2002). Quantitative trait locus mapping in chickens by selective DNA pooling with dinucleotide microsatellite markers by using purified DNA and fresh or frozen red blood cells as applied to marker-assisted selection. Poultry Science 81: 283-292.
86. Liu HC, Cheng HH, Tirunagaru V, Sofer L and Burnside J (2001a). A strategy to identify positional candidate genes conferring Marek's disease resistance by integrating DNA microarrays and genetic mapping. Animal Genetics 32: 351-359.
87. Liu HC, Kung HJ, Fulton JE, Morgan RW and Cheng HH (2001b). Growth hormone interacts with the Marek's disease virus SORF2 protein and is associated with disease resistance in chicken. Proceedings of the National Academy of Sciences of the United States of America 98: 9203-8.
88. Liu HC, Niikura M, Fulton JE and Cheng HH (2003). Identification of chicken lymphocyte antigen 6 complex, locus E (LY6E, alias SCA2) as a putative Marek's disease resistance gene via a virus-host protein interaction screen. Cytogenetic and Genome Research 102: 304-308.
89. Liu JL, Lin SF, Xia L, Brunovskis P, Li D, Davidson I, Lee LF and Kung HJ (1999). MEQ and V-IL8: cellular genes in disguise? Acta Virologica 43: 94-101.
90. Maccubbin DL and Schierman LW (1986). MHC-restricted cytotoxic response of chicken T cells: expression, augmentation, and clonal characterization. Journal of Immunology 136: 12-16.
91. Maneechotesuwan K, Xin Y, Ito K, Jazrawi E, Lee KY, Usmani OS, Barnes PJ and Adcock IM (2007). Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA-3. Journal of Immunology 178: 2491-2498.
92. Marek J (1907). Multiple Nervenentzündung (Polyneuritis) bei Hühnern. Deutsche Tierä rztliche Wochenschrift 15: 417-421.
93. Markowski-Grimsrud CJ and Schat KA (2002). Cytotoxic T lymphocyte responses to Marek's disease herpesvirusencoded glycoproteins. Veterinary Immunology and Immunopathology 90: 133-144.
94. McElroy JP, Dekkers JCM, Fulton JE, O'Sullivan NP, Soller M, Lipkin E, Zhang W, Koehler KJ, Lamont SJ and Cheng HH (2005). Microsatellite markers associated with resistance to Marek's disease in commercial layer chickens. Poultry Science 84: 1678-1688.
95. Merkle H, Cihak J and Losch U (1992). The cytotoxic T lymphocyte response in reticuloendotheliosis virus-infected chickens is mediated by alpha beta and not by gamma delta T cells. Immunobiology 186: 292-303.
96. Mester JC and Rouse BT (1991). The mouse model and understanding immunity to herpes simplex virus. Reviews of Infectious Diseases 13: S935-45.
97. Mester JC, Highlander SL, Osmand AP, Glorioso JC and Rouse BT (1990). Herpes simplex virus type 1-specific immunity induced by peptides corresponding to an antigenic site of glycoprotein B. Journal of Virology 64: 5277-5283.
98. Morgan RW, Sofer L, Anderson AS, Bernberg EL, Cui J and Burnside J (2001). Induction of host gene expression following infection of chicken embryo fibroblasts with oncogenic Marek's disease virus. Journal of Virology 75: 533-539.
99. Morimura T, Ohashi K, Kon Y, Hattori M, Sugimoto C and Onuma M (1997). Apoptosis in peripheral CD4+T cells and thymocytes by Marek's disease virus-infection. Leukemia 11: 206-208.
100. Morrow C and Fehler F (2004). Marek's disease: a worldwide problem. In: Davison F and Nair V (eds) Marek's Disease: An Evolving Problem. London: Elsevier, pp. 49-61.
101. Mossman KL and Ashkar AA (2005). Herpesviruses and the innate immune response. Viral Immunology 18: 267-281.
102. Nazerian K, Lee LF, Yanagida N and Ogawa R (1992). Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus. Journal of Virology 66: 1409-1413.
103. Niemiec PK, Read LR and Sharif S (2006). Synthesis of chicken major histocompatibility complex class II oligomers using a baculovirus expression system. Protein Expression and Purification 46: 390-400.
104. Okazaki W, Purchase HG and Burmester BR (1970). Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Diseases 14: 413-429.
105. Omar AR and Schat KA (1996). Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins. Virology 222: 87-99.
106. Omar AR and Schat KA (1997). Characterization of Marek's disease herpesvirus-specific cytotoxic T lymphocytes in chickens inoculated with a non-oncogenic vaccine strain of MDV. Immunology 90: 579-585.
107. Omar AR, Schat KA, Lee LF and Hunt HD (1998). Cytotoxic T lymphocyte response in chickens immunized with a recombinant fowlpox virus expressing Marek's disease herpesvirus glycoprotein B. Veterinary Immunology and Immunopathology 62: 73-82.
108. Ono M, Maeda K, Kawaguchi Y, Jang HK, Tohya Y, Niikura M and Mikami T (1995). Expression of Marek's disease virus (MDV) serotype 2 gene which has partial homology with MDV serotype 1 pp38 gene. Virus Research 35: 223-229.
109. Osterrieder K and Vautherot JF (2004). The genome content of Marek's disease-like viruses. In: Davison F and Nair V (eds) Marek's Disease an Evolving Problem. London: Elsevier, pp. 17-29.
110. Parcells MS, Lin SF, Dienglewicz RL, Majerciak V, Robinson DR, Chen HC, Wu Z, Dubyak GR, Brunovskis P, Hunt HD, Lee LF and Kung HJ (2001). Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. Journal of Virology 75: 5159-5173.
111. Parvizi P, Read LR, Abdul-Careem MF, Sarson AJ, Lusty C, Lambourne M, Thanthrige-Don N, Burgess SC and Sharif S (2009a). Cytokine gene expression in splenic CD4+ and CD8+ T cell subsets of genetically-resistant and susceptible chickens infected with Marek's disease virus. Veterinary Immunology and Immunopathology 132: 209-17.
112. Parvizi P, Read L, Abdul-Careem MF, Lusty C and Sharif S (2009b). Cytokine gene expression in splenic CD4(+) and CD8(+) T-cell subsets of chickens infected with Marek's disease virus. Viral Immunology 22: 31-38.
113. Praslickova D, Sharif S, Sarson A, Abdul-Careem MF, Zadworny D, Kulenkamp A, Ansah G and Kuhnlein U (2008). Association of a marker in the vitamin D receptor gene with Marek's disease resistance in poultry. Poultry Science 87: 1112-1119.
114. Pratt WD, Morgan R and Schat KA (1992). Cell-mediated cytolysis of lymphoblastoid cells expressing Marek's disease virusspecific phosphorylated polypeptides. Veterinary Microbiology 33: 93-99.
115. Quéré P, Rivas C, Ester K, Novak R and Ragland WL (2005). Abundance of IFN-alpha and IFN-gamma mRNA in blood of resistant and susceptible chickens infected with Marek's disease virus (MDV) or vaccinated with turkey herpesvirus; and MDV inhibition of subsequent induction of IFN gene transcription. Archives of Virology 150: 507-519.
116. Qureshi MA, Heggen CL and Hussain I (2000). Avian macrophage: effector functions in health and disease. Developmental and Comparative Immunology 24: 103-119.
117. Rispens BH, Van Vloten H, Mastenbroek N, Maas HJ and Schat KA (1972a). Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Diseases 16: 108-125.
118. Rispens BH, Van Vloten H, Mastenbroek N, Maas JL and Schat KA (1972b). Control of Marek's disease in the Netherlands. II. Field trials on vaccination with an avirulent strain (CVI 988) of Marek's disease virus. Avian Diseases 16: 126-138.
119. Ross LJ (1977). Antiviral T cell-mediated immunity in Marek's disease. Nature 268: 644-646.
120. Rothwell L, Young JR, Zoorob R, Whittaker CA, Hesketh P, Archer A, Smith AL and Kaiser P (2004). Cloning and characterization of chicken IL-10 and its role in the immune response to Eimeria maxima. Journal of Immunology 173: 2675-2682.
121. Sarson AJ, Abdul-Careem MF, Zhou H and Sharif S (2006). Transcriptional analysis of host responses to Marek's disease viral infection. Viral Immunology 19: 747-758.
122. Sarson AJ, Abdul-Careem MF, Read LR, Brisbin JT and Sharif S (2008a). Expression of cytotoxicity-associated genes in Marek's disease virus-infected chickens. Viral Immunology 21: 267-272.
123. Sarson AJ, Parvizi P, Lepp D, Quinton M and Sharif S (2008b). Transcriptional analysis of host responses to Marek's disease virus infection in genetically resistant and susceptible chickens. Animal Genetics 39: 232-240.
124. Schat KA and Baranowski E (2007). Animal vaccination and the evolution of viral pathogens. Revue Scientifique et Technique (International Office of Epizootics) 26: 327-338.
125. Schat KA and Calnek BW (1978). Protection against Marek's disease-derived tumor transplants by the nononcogenic SB-1 strain of Marek's disease virus. Infection and Immunity 22: 225-232.
126. Schat KA and Davies C (2000). Resistance to viral diseases. In: Axford RFE, Owen JB and Nicholas F (eds) Breeding for Disease Resistance in Farm Animals, 2nd edn. Wallingford, UK: CAB International, pp. 271-300.
127. Schat KA and Xing Z (2000). Specific and nonspecific immune responses to Marek's disease virus. Developmental and Comparative Immunology 24: 201-221.
128. Schat KA and Markowski-Grimsrud CJ (2001). Immune responses to Marek's disease virus infection. Current Topics in Microbiology and Immunology 255: 91-120.
129. Schat KA and Nair V (2008). Marek's disease. In: Saif YM, Fadly AM, Glisson JR, McDougald LR, Nolan LK and Swayne DE (eds) Diseases of Poultry, 12th edn. Iowa State Press, US, Wiley-Blackwell, pp. 458-520.
130. Schat KA, Chen CL, Shek WR and Calnek BW (1982). Surface antigens on Marek's disease lymphoblastoid tumor cell lines. Journal of the National Cancer Institute 69: 715-720.
131. Schat KA, Pratt WD, Morgan R, Weinstock D and Calnek BW (1992). Stable transfection of reticuloendotheliosis virustransformed lymphoblastoid cell lines. Avian Diseases 36: 432-439.
132. Schwarz H, Schneider K, Ohnemus A, Lavric M, Kothlow S, Bauer S, Kaspers B and Staeheli P (2007). Chicken Toll-like receptor 3 recognizes its cognate ligand when ectopically expressed in human cells. Journal of Interferon and Cytokine Research 27: 97-101.
133. Selsted ME and Ouellette AJ (2005). Mammalian defensins in the antimicrobial immune response. Nature Immunology 6: 551-557.
134. Sharma JM and Burmester BR (1982). Resistance to Marek's disease at hatching in chickens vaccinated as embryos with the turkey herpesvirus. Avian Diseases 26: 134-149.
135. Sharma JM and Okazaki W (1981). Natural killer cell activity in chickens: target cell analysis and effect of antithymocyte serum on effector cells. Infection and Immunity 31: 1078-1085.
136. Smith GD, Zelnik V and Ross LJ (1995). Gene organization in herpesvirus of turkeys: identification of a novel open reading frame in the long unique region and a truncated homologue of pp38 in the internal repeat. Virology 207: 205-216.
137. Tarpey I, Davis PJ, Sondermeijer P, Van Geffen C, Verstegen I, Schijns VEJC, Kolodsick J and Sundick R (2007). Expression of chickens interleukin-2 by turkey herpesvirus increases the immune response against Marek's disease virus but fails to increase protection against virulent challenge. Avian Pathology 36: 69-74.
138. Uni Z, Pratt WD, Miller MM, O'Connell PH and Schat KA (1994). Syngeneic lysis of reticuloendotheliosis virus-transformed cell lines transfected with Marek's disease virus genes by virus-specific cytotoxic T cells. Veterinary Immunology and Immunopathology 44: 57-69.
139. Vallejo RL, Bacon LD, Liu H, Witter RL, Groenen MAM, Hillel J and Cheng HH (1998). Genetic mapping of quantitative trait loci affecting susceptibility to Marek's disease virus induced tumors in F sub(2) intercross chickens. Genetics 148: 349-360.
140. Weinstock D, Schat KA and Calnek BW (1989). Cytotoxic T lymphocytes in reticuloendotheliosis virus-infected chickens. European Journal of Immunology 19: 267-272.
141. Witter RL (2001). Protective efficacy of Marek's disease vaccines. In: Hirai K (ed.) Marek's Disease. Berlin, Heidelberg, New York: Springer-Verlag, pp. 57-91.
142. Witter RL and Kreager KS (2004). Serotype 1 viruses modified by backpassage or insertional mutagenesis:approaching the threshold of vaccine efficacy in Marek's disease. Avian Diseases 48: 768-782.
143. Witter RL, Nazerian K, Purchase HG and Burgoyne GH (1970). Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. American Journal of Veterinary Research 31: 525-538.
144. Xing Z and Schat KA (2000a). Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek's disease virus. Journal of Virology 74: 3605-3612.
145. Xing Z and Schat KA (2000b). Expression of cytokine genes in Marek's disease virus-infected chickens and chicken embryo fibroblast cultures. Immunology 100: 70-76.
146. Xu S, Yonash N, Vallejo RL and Cheng HH (1998). Mapping quantitative trait loci for binary traits using a heterogeneous residual variance model: an application to Marek's disease susceptibility in chickens. Genetica 104: 171-178.
147. Yu Y, Zhang H, Tian F, Zhang W, Fang H and Song J (2008). An integrated epigenetic and genetic analysis of DNA methyltransferase genes (DNMTs) in tumor resistant and susceptible chicken lines. PLoS ONE 3: 2672-2685.